Bloomberg -- Novo Nordisk A/S, the world’s biggest diabetes-drug maker, raised its 2010 forecast for the second time this year after first-quarter profit beat analyst estimates on higher-than-expected sales of a new medicine.
Bloomberg -- Novo Nordisk A/S, the world’s biggest diabetes-drug maker, raised its 2010 forecast for the second time this year after first-quarter profit beat analyst estimates on higher-than-expected sales of a new medicine.
